Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
NHSEED - Economic Study or Review
Details- 2012
- Norman R
Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis
NHSEED - Economic Study or Review
Details- 2012
- Urquhart D
A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis
NHSEED - Economic Study or Review
Details- 2012
- Wells J
Economic impact of tobramycin in patients with cystic fibrosis in a managed care population (Provisional abstract)
NHSEED - Economic Study or Review
Details- 2011
- Wertz DA
PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis
NHSEED - Economic Study or Review
Details- 2010
- Tur-Kaspa I
The costs of treatment of early and chronic pseudomonas aeruginosa infection in cystic fibrosis patients
NHSEED - Economic Study or Review
Details- 2009
- Braccini G
Cost analysis for ambulatory treatment of cystic fibrosis patients in Germany: overview of the prospective study results
NHSEED - Economic Study or Review
Details- 2009
- Eidt D
Cost-effective airway cultures in the cystic fibrosis patient
NHSEED - Economic Study or Review
Details- 2009
- Ghegan M D
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.
primary studies published RCT
Details- 2025
- Durieu I
Effectiveness of the hippotherapy simulator in children and adolescents with cystic fibrosis: A randomized controlled trial.
primary studies published RCT
Details- 2025
- Cinar B